RMTG — Regenerative Medical Technology Group Inc.
—
OTC ·
Consumer Discretionary ·
Specialty Retail ·
CIK 1760026 ·
Last close
$0.04
Market Cap
$544.0K
52W High
$0.04
52W Low
$0.02
ADV30
11,821
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 2,639,353 | 1,766,491 | 229,783 | -876,274 | 5,009,582 | 1,061,448 | 40,630,891 |
| Dec 2025 | 1,571,922 | 779,495 | -306,274 | -1,392,843 | 4,488,694 | 956,718 | 39,233,729 |
| Sep 2025 | 1,180,534 | 501,557 | -445,761 | -4,353,741 | 4,519,827 | 1,185,695 | 34,574,268 |
| Jun 2025 | 983,518 | 585,832 | -250,086 | -1,305,785 | 4,486,828 | 1,614,254 | 33,508,078 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-661,504
Investing CF
$-917,977
Financing CF
$1,418,000
CapEx
$-857,395
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.58
As of
2026-06-14
Balance + Analyst (yfinance extras)
Retained Earnings
$-76,241,785
Inventory
$298,201
Receivables
$34,821
ST Investments
—
EBIT TTM
$815,834
Pretax Income TTM
$-7,928,645
Interest Exp TTM
$8,744,479
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$5,100,315
EBITDA
$-506,095
Free Cash Flow
$4,250,739
Enterprise Value
$20,062,426
Total Cash
$1,061,448
Total Debt
$20,578,860
Shares Out
13,138,968
Trailing EPS
$-0.63
Book Value
$-2.40
ROE
—
ROA
-11.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 5,100,315 | -867,162 | -7,812,409 | 4,488,694 | 39,233,729 | — | -706,519 |
| Dec 2024 | 4,107,494 | 81,181 | -5,562,971 | 3,821,429 | 31,178,102 | — | 850,699 |
| Dec 2023 | 2,409,953 | -715,227 | -9,813,666 | 2,879,103 | 24,674,606 | — | -419,199 |
| Dec 2022 | 1,530,223 | -1,184,859 | -5,506,822 | 8,080,273 | 20,062,565 | — | -1,114,136 |
| Dec 2021 | — | — | — | — | — | — | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NSTM | NovelStem International Corp. | $493.3K | $0.01 | — |
| SNBH | SENTIENT BRANDS HOLDINGS INC. | $1.60M | $0.36 | — |
| JZXN | Jiuzi Holdings, Inc. | $2.01M | $1.51 | — |
| FBCD | FBC Holding, Inc. | $2.28M | $0.00 | — |
| FFLO | Free Flow USA, Inc. | $2.50M | $0.08 | — |
News headlines (Yahoo Finance, 1h cache)
RMTG Surges 93% in Revenue, 87% in Gross Profit and 70% in Operating Income for Q1 2026 vs Q1 2025
2026-06-10 11:01 · Yahoo
RMTG Subsidiary Cellgenic Commences Full-Scale Manufacturing at First-of-Its-Kind
2026-03-26 11:55 · Yahoo
RMTG Subsidiary CELLGENIC Introduces Peptide Pen Product Line at Cancún Global Summit
2025-11-18 12:59 · Yahoo
RMTG Subsidiary CELLGENIC Expands into Dominican Republic with New Distribution Partnership
2025-10-21 11:59 · Yahoo
RMTG Expands into Brazil with Strategic Representation Agreement
2025-10-14 11:59 · Yahoo
RMTG's ISSCA Regenerative Medicine Global Summit 2025 Concludes in Cancún with Full Attendance from 30+ Countries
2025-10-08 11:59 · Yahoo
RMTG Partners with BKFC as Official Regenerative Medicine Provider
2025-09-29 12:00 · Yahoo
RMTG Subsidiary Cellgenic to Host Soft Opening of Advanced Cell Therapy Manufacturing Lab in Cancun During September ISSCA Global Summit
2025-08-25 12:00 · Yahoo
RMTG Expands to Northern Argentina and Paraguay with New Affiliate Partnership
2025-07-29 12:00 · Yahoo
RMTG's Successful ISSCA Buenos Aires Argentina Event Draws Hundreds of Physicians, Announces Seven Additional Training Events in 2025
2025-07-24 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.